Protara Therapeutics, Inc (TARA) insider trading
Every open-market stock purchase and sale by Protara Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $1M over the last 12 months (3 sales). No open-market buys.
- Last insider buy: Richard S Levy (Insider), $63.8K, 17 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $1M (3 sales). Last close $2.50 on Oct 21, 2026.
Recent TARA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 30, 2026 | Jesse Shefferman (CEO) | Sold (not open market) | — |
| Jun 30, 2026 | Jesse Shefferman (CEO) | Sold (not open market) | — |
| Jun 30, 2026 | Jesse Shefferman (CEO) | Sold (not open market) | — |
| Jun 30, 2026 | Jesse Shefferman (CEO) | Sold (not open market) | — |
| Jun 29, 2026 | Jesse Shefferman (CEO) | Sold | $882K |
| Jun 29, 2026 | Jesse Shefferman (CEO) | Bought (not open market) | $412K |
| Jun 29, 2026 | Jesse Shefferman (CEO) | Bought (not open market) | — |
| Jun 15, 2026 | Michael Edward Solomon (Insider) | Bought (not open market) | — |
| Jun 15, 2026 | Roger Garceau (Insider) | Bought (not open market) | — |
| Jun 15, 2026 | Luke M Beshar (Insider) | Bought (not open market) | — |
| Jun 15, 2026 | Barry P Flannelly (Insider) | Bought (not open market) | — |
| Jun 15, 2026 | Jane Huang (Insider) | Bought (not open market) | — |
| Jun 15, 2026 | Richard S Levy (Insider) | Bought (not open market) | — |
| Jun 15, 2026 | Gregory Sargen (Insider) | Bought (not open market) | — |
| Jun 15, 2026 | Cynthia Smith (Insider) | Bought (not open market) | — |
| Jun 2, 2026 | William Conkling (C-suite exec) | Sold (not open market) | $26.1K |
| Apr 8, 2026 | Jacqueline Zummo (Officer) | Sold | $6.1K |
| Apr 1, 2026 | Jacqueline Zummo (Officer) | Sold | $119K |
| Jan 26, 2026 | Jesse Shefferman (CEO) | Sold (not open market) | $58.2K |
| Jan 26, 2026 | Jacqueline Zummo (Insider) | Sold (not open market) | $24.8K |
| Jan 26, 2026 | Patrick Fabbio (CFO) | Sold (not open market) | $21.8K |
| Jan 26, 2026 | Hannah Fry (VP) | Sold (not open market) | $9.7K |
| Jan 20, 2026 | Jesse Shefferman (CEO) | Sold (not open market) | $91.4K |
| Jan 20, 2026 | Jacqueline Zummo (Insider) | Sold (not open market) | $36.8K |
| Jan 20, 2026 | Patrick Fabbio (CFO) | Sold (not open market) | $17.2K |
Who's trading TARA
- Jesse Shefferman, CEO: sold $882K (1 sale), last Jun 30, 2026
- Luke M Beshar, Insider: other filings, last Jun 15, 2026
- Barry P Flannelly, Insider: other filings, last Jun 15, 2026
- Roger Garceau, Insider: other filings, last Jun 15, 2026
- Jane Huang, Insider: other filings, last Jun 15, 2026
- Richard S Levy, Insider: other filings, last Jun 15, 2026
- Gregory Sargen, Insider: other filings, last Jun 15, 2026
- Cynthia Smith, Insider: other filings, last Jun 15, 2026
- Michael Edward Solomon, Insider: other filings, last Jun 15, 2026
- William Conkling, C-suite exec: other filings, last Jun 2, 2026
- Jacqueline Zummo, Insider: sold $125K (2 sales), last Apr 8, 2026
- Hannah Fry, VP: other filings, last Jan 26, 2026
- Patrick Fabbio, CFO: other filings, last Jan 26, 2026
- Leonardo Viana Nicacio, C-suite exec: other filings, last Jan 16, 2026
Get free alerts when an insider at Protara Therapeutics, Inc files a new trade →